Genetic reporter system for oncogenic Igh-Myc translocations in mice

Oncogene

Volumn 29, Issue 28, 2010, Pages 4113-4120

  Takizawa, M ^a,b   Kim, J S ^a,e   Tessarollo, L ^a   McNeil, N ^c   Waldschmidt, T J ^d   Casellas, R ^b   Ried, T ^c   Janz, S ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

green fluorescence protein; human Burkitt lymphoma t(8; 14)(q24; q32) translocation; mouse plasmacytoma T(12; 15) translocation

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE INSERTION; GENE TARGETING; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC CODE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE MYC; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE;

ANIMALS; GENES, MYC; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; ONCOGENES; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

MUS;

EID: 77954757627     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.150     Document Type: Article

References (31)

1. Anderson PN, Potter M. (1969). Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane).Nature 222: 994995.
2. Cheng HL, Vuong BQ, Basu U, Franklin A, Schwer B, Astarita J, et al. (2009). Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic ypermutation in mice. Proc Natl Acad Sci USA 106: 2717-2722.
3. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. (1982). Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79: 7824-7827.
4. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE et al. (2000). DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404: 510-514.
5. Eisenman RN. (2001). Deconstructing myc. Genes Dev 15: 2023-2030.
6. Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA et al. (2006). H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell 21: 201-214.
7. Germain RN, Castellino F, Chieppa M, Egen JG, Huang AY, Koo LY et al. (2005). An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol 17: 431-441.
8. Gostissa M, Ranganath S, Bianco JM, Alt FW. (2009a). Chromosomal location targets different MYC family gene members for oncogenic translocations. Proc Natl Acad Sci USA 106: 2265-2270.
9. Gostissa M, Yan CT, Bianco JM, Cogne M, Pinaud E, Alt FW. (2009b). Long-range oncogenic activation of Igh-c-myc transloca-tions by the Igh 3 regulatory region. Nature 462: 803-807.
10. Janz S. (2006). Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 5: 1213-1224.
11. Janz S, Müller J, Shaughnessy J, Potter M. (1993). Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc Natl Acad Sci USA 90: 7361-7365.
12. Kovalchuk AL, Kim JS, Janz S. (2003). E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells. Oncogene 22: 2842-2850.
13. Kovalchuk AL, Kishimoto T, Janz S. (2000a). Lymph nodes and Peyers patches of IL-6 transgenic BALB/c mice harbor T(12;15) translocated plasma cells that contain illegitimate exchanges between the immunoglobulin heavy-chain mu locus and c-myc. Leukemia 14: 1127-1135.
14. Kovalchuk AL, Müller JR, Janz S. (1997). Deletional remodeling of c-myc-deregulating translocations. Oncogene 15: 2369-2377.
15. Kovalchuk AL, Mushinski EB, Janz S. (2000b). Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations. Leukemia 14: 909-921.
16. Kuppers R, Dalla-Favera R. (2001). Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20: 5580-5594.
17. Levens DL. (2003). Reconstructing MYC. Genes Dev 17: 1071-1077.
18. Mitelman F, Johansson B, Mertens F. (2007). The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245.
19. Müller JR, Jones GM, Janz S, Potter M. (1997a). Migration of cells with immunoglobulin/c-myc recombinations in lymphoid tissues of mice. Blood 89: 291-296.
20. Müller JR, Jones GM, Potter M, Janz S. (1996). Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction. Cancer Res 56: 419-423.
21. Müller JR, Mushinski EB, Jones GM, Williams JA, Janz S, Hausner PF et al. (1997b). Generation of immunoglobulin/c-myc recombinations in murine Peyers patch follicles. Curr Top Microbiol Immunol 224: 251-255.
22. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. (2000). Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
23. Nussenzweig A, Sokol K, Burgman P, Li L, Li GC. (1997). Hypersensitivity of Ku80-deficient cell lines and mice to DNA damage: the effects of ionizing radiation on growth, survival, and development. Proc Natl Acad Sci USA 94: 13588-13593.
24. Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, Cordon-Cardo C et al. (1997). Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J Exp Med 186: 921-929.
25. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M et al. (2004). AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118: 431-438.
26. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S et al. (2008). AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135: 1028-1038.
27. Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S. (2003). BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Cancer Res 63: 8656-8663.
28. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K et al. (1992). Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 89: 232-235.
29. Wang JH, Gostissa M, Yan CT, Goff P, Hickernell T, Hansen E et al. (2009). Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 460: 231-236.
30. Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA. (2007). In vivo imaging in experimental preclinical tumor research - a review. Cytometry A 71: 542-549.
31. Willis TG, Dyer MJ. (2000). The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96: 808-822.